Benefis Sletten Cancer Institute is
Montana's most comprehensive and state-of-the-art cancer facility.
Benefis SCI has been uniquely designed to care for the mind, body and
spirit of cancer patients and their caregivers.
Our team of
expert medical oncologists and radiation oncologists, nurses and other
cancer care professionals are dedicated to providing advanced cancer
treatment, research and education to their fellow Montanans. Equally as
important, Benefis SCI provides a truly progressive approach to
preventing and diagnosing cancer.
best management and treatment for cancer patients is in a clinical trial
says the National Comprehensive Cancer Network (NCCN). Benefis Sletten
Cancer Institute agrees and encourages all cancer patients to
participate in clinical trials when possible.
Clinical trials are
research studies conducted with patients to evaluate new forms of
intervention with the hope of improving or extending the cancer
patient’s life. Patients in clinical trials may be the first to receive
promising new treatments before they become widely available.
Chemotherapy, Hormone Therapy and Immunotherapy
Sletten Cancer Instiute’s medical Oncologists are dedicated to finding
better ways to detect and treat cancer. Medical oncologists administer a
variety of cancer therapies including chemotherapy, hormonal treatments
and biological therapies. In addition to our anti-cancer therapies,
care includes intravenous fluids and feedings, antibiotics, blood
products and many other drugs that prevent and control symptoms. Our
services are provided in the convenience and comfort of an outpatient
Benefis Sletten Cancer
Institute’s Radiation Oncology department is the first and only
radiation oncology provider in Great Falls to offer the most experienced
physicians, staff, and services since the 1970s. With our experience
and accreditation through the American College of Surgeons, there is no
other program that offers equivalent capabilities in the entire state.
are proud to say that our physicians and staff are all board certified
in their respective areas, and most importantly, care for you and your
family with the highest level of compassion and care.
CyberKnife®: Giving Hope to Patients and Families
Sletten Cancer Institute in Great Falls is the first to offer
CyberKnife® in Montana, North Dakota, South Dakota, Idaho, and
Wyoming. CyberKnife® is the world’s first robotic Radiosurgery tool
offering hope to patients with both benign and malignant conditions –
even conditions that were thought to be inoperable.
ability to deliver radiation from over 1,200 positions, the CyberKnife®
is the first to allow Radiosurgery to be performed successfully anywhere
in the body. Other advantages include:
- 1-5 Days of Treatment
- No pain
- No incision
- No blood loss
- No recovery time – patients go home immediately
- Provides an improved quality of life
- Extremely accurate, with sub-millimeter of accuracy
- No invasive head frame required
- Provides real-time tracking of tumor and patient movement, and compensates to ensure treatment accuracy
Please call us today at 1.800.227.4518 to see if CyberKnife® is right for you!
Sletten Cancer Institute offers Mammosite, a targeted radiation
therapy, to women with early stage breast cancer. Mammosite delivers
radiation from within the breast limiting the exposure of healthy cells
to radiation. Women eligible for Mammosite complete their treatments in
five days compared to the six or seven weeks of external beam
The hematologists at Benefis
Sletten Cancer Institute are dedicated to providing state-of-the-art
treatment of blood and clotting disorders. These disorders include
anemia, bone marrow failure syndromes, acute and chronic leukemia,
multiple myeloma and venous thrombosis syndromes.
specialists are trained in the management of adult and pediatric blood
disorders. Physicians work in a multi-disciplinary manner with other
specialists to manage complex cases. The hematologists are routinely
consulted by primary care physicians from the entire Northcentral
Montana region to assist in the diagnosis and management of blood
disorders. Improving the treatment outcomes and quality of life for
patients with these disorders is our mission.